{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:51:37Z","timestamp":1776153097678,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"Instituto de Salud Carlos III.Co-funded by European Regional Development Fund\/European Social Fund \"A way to make Europe\"\/\"Investing in your future\").","doi-asserted-by":"publisher","award":["PI16\/0142"],"award-info":[{"award-number":["PI16\/0142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0470-2019"],"award-info":[{"award-number":["PEER-0470-2019"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Instituto de Salud Carlos III (ES).Co-funded by European Regional Development Fund\/European Social Fund \"A way to make Europe\"\/\"Investing in your future\").","doi-asserted-by":"publisher","award":["PI19\/01550"],"award-info":[{"award-number":["PI19\/01550"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The relevant role of long non-coding RNAs (lncRNAs) in cancer is currently a matter of increasing interest. Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor (2\u20135% of all thyroid cancer) derived from the parafollicular C-cells which secrete calcitonin. About 75% of all medullary thyroid cancers are believed to be sporadic medullary thyroid cancer (sMTC), whereas the remaining 25% correspond to inherited cancer syndromes known as Multiple Endocrine Neoplasia type 2 (MEN2). MEN2 syndrome, with autosomal dominant inheritance is caused by germline gain of function mutations in <jats:italic>RET<\/jats:italic> proto-oncogene. To date no lncRNA has been associated to MEN2 syndrome and only two articles have been published relating long non-coding RNA (lncRNA) to MTC: the first one linked <jats:italic>MALAT1<\/jats:italic> with sMTC and, in the other, our group determined some new lncRNAs in a small group of sMTC cases in fresh tissue (<jats:italic>RMST, FTX<\/jats:italic>, <jats:italic>IPW<\/jats:italic>, <jats:italic>PRNCR1<\/jats:italic>, <jats:italic>ADAMTS9-AS2<\/jats:italic> and <jats:italic>RMRP<\/jats:italic>). The aim of the current study is to validate such novel lncRNAs previously described by our group by using a larger cohort of patients, in order to discern their potential role in the disease. Here we have tested three up-regulated (<jats:italic>RMST, FTX<\/jats:italic>, <jats:italic>IPW<\/jats:italic>) and one down-regulated (<jats:italic>RMRP<\/jats:italic>) lncRNAs in our samples (formalin fixed paraffin embedded tissues from twenty-one MEN2 and ten sMTC patients) by RT-qPCR analysis. The preliminary results reinforce the potential role of <jats:italic>RMST, FTX<\/jats:italic>, <jats:italic>IPW<\/jats:italic> and <jats:italic>RMRP<\/jats:italic> in the pathogenesis of MTC.<\/jats:p>","DOI":"10.1186\/s13023-020-01665-5","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T19:04:06Z","timestamp":1609959846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Berta","family":"Luz\u00f3n-Toro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Villalba-Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Mar\u00eda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Torroglosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Anti\u00f1olo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-6161","authenticated-orcid":false,"given":"Salud","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"12","key":"1665_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2009.1607","volume":"19","author":"MR Vriens","year":"2009","unstructured":"Vriens MR, Suh I, Moses W, Kebebew E. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid Offic J Am Thyroid Assoc. 2009;19(12):1343\u20139.","journal-title":"Thyroid Offic J Am Thyroid Assoc"},{"issue":"3","key":"1665_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184\u201399.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1665_CR3","first-page":"281","volume":"21","author":"Z Javed","year":"2020","unstructured":"Javed Z, Ahmed Shah F, Rajabi S, Raza Q, Iqbal Z, Ullah M, et al. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer. APJCP. 2020;21(2):281\u20137.","journal-title":"APJCP"},{"issue":"1","key":"1665_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.1999.17.1.380","volume":"17","author":"C Eng","year":"1999","unstructured":"Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol Offic J Am Soc Clin Oncol. 1999;17(1):380\u201393.","journal-title":"J Clin Oncol Offic J Am Soc Clin Oncol"},{"key":"1665_CR5","doi-asserted-by":"publisher","first-page":"3651051","DOI":"10.1155\/2020\/3651051","volume":"2020","author":"Y Rao","year":"2020","unstructured":"Rao Y, Liu H, Yan X, Wang J. In Silico Analysis Identifies Differently Expressed lncRNAs as Novel Biomarkers for the Prognosis of Thyroid Cancer. Comput Math Methods Med. 2020;2020:3651051.","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"1665_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/MED.0000000000000497","volume":"26","author":"M Sedaghati","year":"2019","unstructured":"Sedaghati M, Kebebew E. Long noncoding RNAs in thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2019;26(5):275\u201381.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"1665_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10520295.2018.1446101","volume":"93","author":"EF Gaffney","year":"2018","unstructured":"Gaffney EF, Riegman PH, Grizzle WE, Watson PH. Factors that drive the increasing use of FFPE tissue in basic and translational cancer research. Biotech Histochem Offic Publ Biol Stain Comm. 2018;93(5):373\u201386.","journal-title":"Biotech Histochem Offic Publ Biol Stain Comm"},{"issue":"4","key":"1665_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12022-019-09589-y","volume":"30","author":"Y Wang","year":"2019","unstructured":"Wang Y, Hardin H, Chu YH, Esbona K, Zhang R, Lloyd RV. Long non-coding RNA expression in anaplastic thyroid carcinomas. Endocr Pathol. 2019;30(4):262\u20139.","journal-title":"Endocr Pathol"},{"issue":"19","key":"1665_CR9","first-page":"1575","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. Int RET Mutat Consort Anal JAMA. 1996;276(19):1575\u20139.","journal-title":"Int RET Mutat Consort Anal JAMA"},{"issue":"4","key":"1665_CR10","first-page":"575","volume":"17","author":"RM Fernandez","year":"2006","unstructured":"Fernandez RM, Navarro E, Antinolo G, Ruiz-Ferrer M, Borrego S. Evaluation of the role of RET polymorphisms\/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Int J Mol Med. 2006;17(4):575\u201381.","journal-title":"Int J Mol Med"},{"key":"1665_CR11","doi-asserted-by":"crossref","unstructured":"Sanchez B, Antinolo G, Navarro E, Japon MA, Conde AF, Astorga R, et al. Cys 634 mutations in the RET proto-oncogene in Spanish families affected by MEN 2A. Human mutation. 1998;Suppl 1:S72\u20133.","DOI":"10.1002\/humu.1380110125"},{"issue":"1","key":"1665_CR12","first-page":"68","volume":"36","author":"B Sanchez","year":"1999","unstructured":"Sanchez B, Robledo M, Biarnes J, Saez ME, Volpini V, Benitez J, et al. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. J Med Genet. 1999;36(1):68\u201370.","journal-title":"J Med Genet"},{"issue":"11","key":"1665_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/jmg.37.11.817","volume":"37","author":"JR Hansford","year":"2000","unstructured":"Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000;37(11):817\u201327.","journal-title":"J Med Genet"},{"issue":"1","key":"1665_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40291-017-0303-y","volume":"22","author":"M Zarkesh","year":"2018","unstructured":"Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M. Altered epigenetic mechanisms in thyroid cancer subtypes. Mol Diagn Ther. 2018;22(1):41\u201356.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"1665_CR15","first-page":"551","volume":"53","author":"X Li","year":"2018","unstructured":"Li X, Zhao Q, Qi J, Wang W, Zhang D, Li Z, et al. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPAR\u03b3 pathway in hepatocellular carcinoma. Int J Oncol. 2018;53(2):551\u201366.","journal-title":"Int J Oncol"},{"issue":"2","key":"1665_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jcp.29055","volume":"235","author":"N Shabani","year":"2020","unstructured":"Shabani N, Sheikholeslami S, Paryan M, Zarif Yeganeh M, Tavangar SM, Azizi F, et al. An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients. J Cell Physiol. 2020;235(2):1366\u201373.","journal-title":"J Cell Physiol"},{"issue":"2","key":"1665_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.yexmp.2017.10.002","volume":"103","author":"YH Chu","year":"2017","unstructured":"Chu YH, Hardin H, Schneider DF, Chen H, Lloyd RV. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. Exp Mol Pathol. 2017;103(2):229\u201336.","journal-title":"Exp Mol Pathol"},{"key":"1665_CR18","first-page":"1","volume":"4","author":"BFR Luz\u00f3n-Toro","year":"2019","unstructured":"Luz\u00f3n-Toro BFR, Martos-Mart\u00ednez JM, Anti\u00f1olo G, Borrego S. Identification of new long non-coding RNAs associated with medullary thyroid cancer. Oral Health Care. 2019;4:1\u20133.","journal-title":"Oral Health Care"},{"issue":"11","key":"1665_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/genes10110913","volume":"10","author":"B Luz\u00f3n-Toro","year":"2019","unstructured":"Luz\u00f3n-Toro B, Fern\u00e1ndez RM, Villalba-Benito L, Torroglosa A, Anti\u00f1olo G, Borrego S. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis. Genes. 2019;10(11):913.","journal-title":"Genes"},{"issue":"2","key":"1665_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1034\/j.1399-0004.2002.610210.x","volume":"61","author":"L Bonaf\u00e9","year":"2002","unstructured":"Bonaf\u00e9 L, Schmitt K, Eich G, Giedion A, Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. Clin Genet. 2002;61(2):146\u201351.","journal-title":"Clin Genet"},{"issue":"6","key":"1665_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ng.2968","volume":"46","author":"Y Stelzer","year":"2014","unstructured":"Stelzer Y, Sagi I, Yanuka O, Eiges R, Benvenisty N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nat Genet. 2014;46(6):551\u20137.","journal-title":"Nat Genet"},{"issue":"5","key":"1665_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/497708","volume":"77","author":"CT Thiel","year":"2005","unstructured":"Thiel CT, Horn D, Zabel B, Ekici AB, Salinas K, Gebhart E, et al. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet. 2005;77(5):795\u2013806.","journal-title":"Am J Hum Genet"},{"key":"1665_CR23","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.2147\/OTT.S170439","volume":"11","author":"Y Xu","year":"2018","unstructured":"Xu Y, Wang J, Wang J. Long noncoding RNA XIST promotes proliferation and invasion by targeting miR-141 in papillary thyroid carcinoma. OncoTargets Therapy. 2018;11:5035\u201343.","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"1665_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/jmedgenet-2019-106131","volume":"57","author":"S Vakkilainen","year":"2020","unstructured":"Vakkilainen S, Costantini A, Taskinen M, Wartiovaara-Kautto U, M\u00e4kitie O. \u201cMetaphyseal dysplasia without hypotrichosis\u201d can present with late-onset extraskeletal manifestations. J Med Genet. 2020;57(1):18\u201322.","journal-title":"J Med Genet"},{"issue":"5","key":"1665_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41434-018-0026-7","volume":"25","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhang J, Chen X, Xu X, Cao G, Li H, et al. LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression. Gene Ther. 2018;25(5):321\u201330.","journal-title":"Gene Ther"},{"key":"1665_CR26","doi-asserted-by":"crossref","unstructured":"Luzon-Toro B, Fernandez RM, Villalba-Benito L, Torroglosa A, Antinolo G, Borrego S. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis. Genes. 2019;10(11).","DOI":"10.3390\/genes10110913"},{"issue":"1","key":"1665_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ymthe.2019.09.024","volume":"28","author":"WX Peng","year":"2020","unstructured":"Peng WX, Koirala P, Zhang W, Ni C, Wang Z, Yang L, et al. lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR. Mol Therapy J Am Soc Gene Therapy. 2020;28(1):9\u201318.","journal-title":"Mol Therapy J Am Soc Gene Therapy"},{"issue":"2","key":"1665_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3748\/wjg.v25.i2.220","volume":"25","author":"JX Gu","year":"2019","unstructured":"Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, et al. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World J Gastroenterol. 2019;25(2):220\u201332.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1665_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13046-019-1306-9","volume":"38","author":"P Dong","year":"2019","unstructured":"Dong P, Xiong Y, Yue J, Xu D, Ihira K, Konno Y, et al. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes. J Exp Clin Cancer Res . 2019;38(1):295.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1665_CR30","doi-asserted-by":"publisher","first-page":"e22293","DOI":"10.1002\/jcla.22293","volume":"32","author":"L Wang","year":"2018","unstructured":"Wang L, Shen Y-F, Shi Z-M, Shang X-J, Jin D-L, Xi F. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11. J Clin Lab Anal. 2018;32(3):e22293.","journal-title":"J Clin Lab Anal"},{"key":"1665_CR31","unstructured":"Grimm D, Bauer J, Wise P, Kr\u00fcger M, Simonsen U, Wehland M, et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2019:S1044\u2013579X(18)30141-X."},{"issue":"5","key":"1665_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.medcli.2008.06.021","volume":"133","author":"R S\u00e1nchez-Ortiga","year":"2009","unstructured":"S\u00e1nchez-Ortiga R, Boix Carre\u00f1o E, Moreno-P\u00e9rez O, Pic\u00f3 AA. Glioblastoma multiforme and multiple endocrine neoplasic type 2 A. Med Clin (Barc). 2009;133(5):196\u20137.","journal-title":"Med Clin (Barc)"},{"key":"1665_CR33","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.2147\/OTT.S213371","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang J, Xiao T, Zhao M. MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP. OncoTargets Therapy. 2019;12:7307\u201321.","journal-title":"OncoTargets Therapy"},{"key":"1665_CR34","doi-asserted-by":"crossref","unstructured":"Vakkilainen S, Taskinen M, Klemetti P, Pukkala E, M\u00e4kitie O. A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia. Frontiers in Immunology. 2019;10(1581).","DOI":"10.3389\/fimmu.2019.01581"},{"issue":"4","key":"1665_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15384047.2019.1702405","volume":"21","author":"S Huang","year":"2020","unstructured":"Huang S, Zhu X, Ke Y, Xiao D, Liang C, Chen J, et al. LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a\/TXNRD1. Cancer Biol Ther. 2020;21(4):379\u201387.","journal-title":"Cancer Biol Ther"},{"key":"1665_CR36","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2147\/OTT.S241011","volume":"13","author":"K Zhao","year":"2020","unstructured":"Zhao K, Ye Z, Li Y, Li C, Yang X, Chen Q, et al. LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p\/EIF5A2 Axis. OncoTargets and therapy. 2020;13:2677\u201388.","journal-title":"OncoTargets and therapy"},{"key":"1665_CR37","doi-asserted-by":"crossref","unstructured":"Liu H, Deng H, Zhao Y, Li C, Liang Y. LncRNA XIST\/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res. 2018;37(1):279-.","DOI":"10.1186\/s13046-018-0950-9"},{"issue":"2","key":"1665_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11154-019-09502-2","volume":"20","author":"G Muscogiuri","year":"2019","unstructured":"Muscogiuri G, Formoso G, Pugliese G, Ruggeri RM, Scarano E, Colao A, et al. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications. Rev Endocr Metab Disorders. 2019;20(2):239\u201350.","journal-title":"Rev Endocr Metab Disorders"},{"issue":"2","key":"1665_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/jpem-2018-0388","volume":"32","author":"L Iughetti","year":"2019","unstructured":"Iughetti L, Vivi G, Balsamo A, Corrias A, Crin\u00f2 A, Delvecchio M, et al. Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients. JPEM. 2019;32(2):159\u201365.","journal-title":"JPEM"},{"issue":"1","key":"1665_CR40","doi-asserted-by":"publisher","first-page":"14374","DOI":"10.1038\/s41598-019-50913-7","volume":"9","author":"B Luzon-Toro","year":"2019","unstructured":"Luzon-Toro B, Fernandez RM, Martos-Martinez JM, Rubio-Manzanares-Dorado M, Antinolo G, Borrego S. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Sci Rep. 2019;9(1):14374.","journal-title":"Sci Rep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01665-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01665-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01665-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T22:09:50Z","timestamp":1610230190000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01665-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01665-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A written informed consent was obtained from all the participants for clinical and molecular genetic studies, after a full explanation of the purpose and nature of all procedures used. The study was approved by the Ethics Committee for clinical research in the University Hospital Virgen del Roc\u00edo (Seville, Spain) and complies with the tenets of the declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}